Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIO-PLEXUS ANNOUNCES FIRST INTERNATIONAL CONTRACT.


TOLLAND, Conn.--(BUSINESS WIRE)--Aug. 15, 1996--Bio-Plexus, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
, NM:BPLX), designer, developer, manufacturer and marketer of safety medical products under the Punctur-Guard(R) name, announced today that it has entered into an agreement with a medical products distributor to sell Bio-Plexus' Punctur-Guard(R) safety needles in Italy. The distributor has agreed to order a minimum of one million needles every six months for two years.

"This is a significant event not only for Bio-Plexus, but also for the European European

emanating from or pertaining to Europe.


European bat lyssavirus
see lyssavirus.

European beech tree
fagussylvaticus.

European blastomycosis
see cryptococcosis.
 healthcare community," said Ron Haverl, chairman and chief executive officer.

"Historically, the U.S. has led the way in providing safety products for healthcare workers. However, recent action on the part of some European governments is leading to a greater acceptance of safety products in the international marketplace. We are optimistic op·ti·mist  
n.
1. One who usually expects a favorable outcome.

2. A believer in philosophical optimism.



op
 that the growing European market for safety products will augment aug·ment  
v. aug·ment·ed, aug·ment·ing, aug·ments

v.tr.
1. To make (something already developed or well under way) greater, as in size, extent, or quantity:
 our increasing domestic sales," Haverl added.

CONTACT: Porter, Le Vay & Rose, Inc.

Marilynn Meek meek  
adj. meek·er, meek·est
1. Showing patience and humility; gentle.

2. Easily imposed on; submissive.
 

212/564-4700

or

Bio-Plexus, Inc.

Christina Tamburro

860/871-8601
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 15, 1996
Words:164
Previous Article:OneWave, Inc. Introduces OneWave Apps(TM) for Integrating and Extending Business Processes; Pre-Built Application Templates to be Offered as Part of...
Next Article:Barilla, Italy's Leading Pasta Maker, Names Robert Black General Manager of U.S. Operations.
Topics:



Related Articles
Bio-Plexus sets distribution pact with Baxter Healthcare; reports 4th quarter/year-end results; announces new product developments.
Kaiser Permanente region to use Punctur-Guard needle.
NY Hospital-Cornell Medical Center and Oregon Medical Labs to use Bio-Plexus' Punctur-Guard needle.
Prestigious hospitals in Miami and Philadelphia to use Bio-Plexus Punctur-Guard(R) needle.
Bio-Plexus needle chosen by two major hospitals; new generation machine installed.
Bio-Plexus announces I.V. catheter license and supply agreement with Johnson & Johnson Medical.
Bio-Plexus signs agreement with division of AmeriNet.
Bio-Plexus Announces New Terms and Year-End Results.
Bio-Plexus and Graphic Control Sign Distribution Agreement.
Plexus to supply Patientline units in UK.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles